Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct;43(5):509-22.
doi: 10.1007/s15010-015-0795-5. Epub 2015 May 19.

Ageing with HIV: a multidisciplinary review

Affiliations
Review

Ageing with HIV: a multidisciplinary review

A Calcagno et al. Infection. 2015 Oct.

Erratum in

  • Erratum to: Ageing with HIV: a multidisciplinary review.
    Calcagno A, Nozza S, Mussi C, Celesia BM, Carli F, Piconi S, De Socio GV, Cattelan AM, Orofino G, Ripamonti D, Riva A, Di Perri G. Calcagno A, et al. Infection. 2015 Oct;43(5):627. doi: 10.1007/s15010-015-0808-4. Infection. 2015. PMID: 26104726 No abstract available.

Abstract

Introduction: After the introduction of highly active antiretroviral treatment, the course of HIV infection turned into a chronic disease and most of HIV-positive patients will soon be over 50 years old.

Material and methods: This paper reviews the multiple aspects that physicians have to face while taking care of HIV-positive ageing patients including the definitions of frailty and the prevalence and risk factors of concomitant diseases. From a therapeutic point of view pharmacokinetic changes and antiretroviral-specific toxicities associated with ageing are discussed; finally therapeutic approaches to frailty are reviewed both in HIV-positive and negative patients.

Conclusion and discussion: We conclude by suggesting that the combined use of drugs with the least toxicity potential and the promotion of healthy behaviours (including appropriate nutrition and exercise) might be the best practice for ageing HIV-positive subjects.

Keywords: Ageing; Comorbidities; Frailty; HIV; Immune senescence; Pharmacokinetics; Toxicity.

PubMed Disclaimer

References

    1. J Virol. 2011 Jul;85(13):6557-66 - PubMed
    1. Med Care. 2006 Aug;44(8 Suppl 2):S13-24 - PubMed
    1. PLoS One. 2011;6(7):e22661 - PubMed
    1. Clin Infect Dis. 2011 Jul 1;53(1):84-91 - PubMed
    1. Curr HIV/AIDS Rep. 2014 Sep;11(3):263-70 - PubMed

Publication types

Substances

LinkOut - more resources